There’s no question that GLP-1 receptor agonist drugs like Wegovy and Ozempic have shifted how we think about weight: although GLP-1s have been used for years to treat diabetes, the latest research has found that this class of medications can have a profound impact on metabolic health and other weight loss benefits.

But there are many misconceptions that persist about these metabolic marvels. At the Flow Space Women’s Health Summit on October 14 in Los Angeles, three expert doctors convened for a panel to bust myths and talk about what role GLP-1s play in the emerging science about metabolic health.

Read more at: https://www.theflowspace.com/physical-health/prevention-longevity/glp1-myths-3006837/